Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Sep 23;15(9):e45815.
doi: 10.7759/cureus.45815. eCollection 2023 Sep.

Progressive Multifocal Leukoencephalopathy Presenting as Primary CNS Malignancy in an Immunocompetent Patient

Affiliations
Case Reports

Progressive Multifocal Leukoencephalopathy Presenting as Primary CNS Malignancy in an Immunocompetent Patient

Rachel D Truong et al. Cureus. .

Abstract

Progressive multifocal leukoencephalopathy (PML) is an infection caused by the John Cunningham virus (JCV), usually in an immunocompromised host. We present the case of a 74-year-old male who presented with a six-week history of progressive memory loss, episodic confusion, and aphasia. Cranial nerve, motor, sensory, and coordination testing were unremarkable. Magnetic resonance imaging (MRI) of the brain and spectroscopy were concerning for primary CNS lymphoma vs. diffuse glioma. Microscopic examination after the patient underwent left frontal stereotactic brain biopsy was suggestive of a viral infection, and further testing with JCV DNA in-situ hybridization (ISH) confirmed the diagnosis of PML. The patient's condition started resolving without treatment. This case demonstrates, to our knowledge, the first known case of primary PML masquerading as CNS lymphoma in modern literature.

Keywords: cns lymphoma; immunocompetent; jc virus; malignancy; pml; progressive multifocal leukoencephalopathy.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Key images from MRI brain with and without contrast, perfusion imaging, and MR spectroscopy
(a) T2 flair post-contrast showing diffuse abnormal left-hemispheric signaling (yellow arrows). (b) T2 flair post-contrast showing progression of diffuse abnormal left-hemispheric signaling (yellow arrows). (c) MRI perfusion showing elevated cerebral blood volume at the multilobar left hemispheric area of involvement (yellow circle). (d) MR spectroscopy showing a decrease in N-acetyl aspartate (yellow arrow).
Figure 2
Figure 2. Key images from MRI brain with and without contrast and perfusion imaging
(a) T2 flair post-contrast showing improvement of abnormal left-hemispheric signaling (yellow arrows). (b) T2 flair post-contrast showing abnormal left-hemispheric signaling, improved from initial study (yellow arrows). (c) MRI perfusion showing decreased cerebral blood volume compared to patient's initial study (yellow circle). (d) MRI perfusion showing persistence of decreased cerebral blood volume compared to prior study (yellow circle).

References

    1. Progressive multifocal leukoencephalopathy: current insights. Kartau M, Sipilä JO, Auvinen E, Palomäki M, Verkkoniemi-Ahola A. Degener Neurol Neuromuscul Dis. 2019;9:109–121. - PMC - PubMed
    1. Progressive multifocal leukoencephalopathy in an immunocompetent patient: a case report and review of literature. Sriwastava S, Khan E, Khalid SH, Kaur A, Feizi P. J Med Virol. 2022;94:2860–2869. - PubMed
    1. Severe progressive multifocal leukoencephalopathy (PML) and spontaneous immune reconstitution inflammatory syndrome (IRIS) in an immunocompetent patient. Krey L, Raab P, Sherzay R, Berding G, Stoll M, Stangel M, Wegner F. Front Immunol. 2019;10:1188. - PMC - PubMed
    1. Progressive multifocal leukoencephalopathy in the absence of immunosuppression. Zucker BE, Stacpoole SR. J Neurovirol. 2018;24:119–122. - PMC - PubMed
    1. Progressive multifocal leukoencephalopathy—a case report in an immunocompetent patient. Faceira A, Magalhães D, Ceia F, Nuak J, Reis C, Ferreira S. Adv Infect Dis. 2018;8:10–16.

Publication types

LinkOut - more resources